GO:0016323; C:basolateral plasma membrane; IEA:Ensembl
GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW
GO:0016020; C:membrane; IDA:UniProtKB
GO:0005886; C:plasma membrane; IDA:MGI
GO:0031088; C:platelet dense granule membrane; IDA:MGI
GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; NAS:UniProtKB
GO:0005524; F:ATP binding; IEA:UniProtKB-KW
GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
GO:0007596; P:blood coagulation; TAS:Reactome
GO:0055114; P:oxidation-reduction process; NAS:GOC
GO:0030168; P:platelet activation; TAS:Reactome
GO:0002576; P:platelet degranulation; TAS:Reactome
GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
GO:0042493; P:response to drug; IEA:Ensembl
GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
GO:0055085; P:transmembrane transport; TAS:Reactome